Amantadine for Executive Dysfunction Syndrome in Patients with Dementia

Shannon J. Drayton, Kendra Davies, Martin Steinberg, Iracema Leroi, Adam Rosenblatt, Constantine G. Lyketsos

Research output: Contribution to journalArticle

Abstract

This article reports the results of an open uncontrolled chart review study of amantadine treatment for executive dysfunction syndrome in patients with dementia. All patients admitted to the neuropsychiatry or geriatric psychiatry inpatient units of Johns Hopkins Hospital in 2000 and 2001 who were treated empirically with amantadine for executive dysfunction syndrome were included in the review. Of the 30 patients whose cases were reviewed, 17 (57%) were at least "much improved," and most patients were discharged taking amantadine, suggesting that their physicians believed that they may have benefited from it. The medication was well tolerated in this frail group of patients. Most patients were taking one or more concurrent psychotropic medications, which may have contributed to the positive outcomes, Despite its limitations, this study offers preliminary data to support a controlled trial of amantadine in patients with executive dysfunction syndrome.

Original languageEnglish (US)
Pages (from-to)205-209
Number of pages5
JournalPsychosomatics
Volume45
Issue number3
DOIs
StatePublished - May 2004

Fingerprint

Amantadine
Dementia
Neuropsychiatry
Geriatric Psychiatry
Syndrome
Inpatients
Physicians

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Psychology(all)

Cite this

Amantadine for Executive Dysfunction Syndrome in Patients with Dementia. / Drayton, Shannon J.; Davies, Kendra; Steinberg, Martin; Leroi, Iracema; Rosenblatt, Adam; Lyketsos, Constantine G.

In: Psychosomatics, Vol. 45, No. 3, 05.2004, p. 205-209.

Research output: Contribution to journalArticle

Drayton, Shannon J. ; Davies, Kendra ; Steinberg, Martin ; Leroi, Iracema ; Rosenblatt, Adam ; Lyketsos, Constantine G. / Amantadine for Executive Dysfunction Syndrome in Patients with Dementia. In: Psychosomatics. 2004 ; Vol. 45, No. 3. pp. 205-209.
@article{0e9f09728dd4411bb7769c13dc2be0e5,
title = "Amantadine for Executive Dysfunction Syndrome in Patients with Dementia",
abstract = "This article reports the results of an open uncontrolled chart review study of amantadine treatment for executive dysfunction syndrome in patients with dementia. All patients admitted to the neuropsychiatry or geriatric psychiatry inpatient units of Johns Hopkins Hospital in 2000 and 2001 who were treated empirically with amantadine for executive dysfunction syndrome were included in the review. Of the 30 patients whose cases were reviewed, 17 (57{\%}) were at least {"}much improved,{"} and most patients were discharged taking amantadine, suggesting that their physicians believed that they may have benefited from it. The medication was well tolerated in this frail group of patients. Most patients were taking one or more concurrent psychotropic medications, which may have contributed to the positive outcomes, Despite its limitations, this study offers preliminary data to support a controlled trial of amantadine in patients with executive dysfunction syndrome.",
author = "Drayton, {Shannon J.} and Kendra Davies and Martin Steinberg and Iracema Leroi and Adam Rosenblatt and Lyketsos, {Constantine G.}",
year = "2004",
month = "5",
doi = "10.1176/appi.psy.45.3.205",
language = "English (US)",
volume = "45",
pages = "205--209",
journal = "Psychosomatics",
issn = "0033-3182",
publisher = "American Psychiatric Publishing Inc.",
number = "3",

}

TY - JOUR

T1 - Amantadine for Executive Dysfunction Syndrome in Patients with Dementia

AU - Drayton, Shannon J.

AU - Davies, Kendra

AU - Steinberg, Martin

AU - Leroi, Iracema

AU - Rosenblatt, Adam

AU - Lyketsos, Constantine G.

PY - 2004/5

Y1 - 2004/5

N2 - This article reports the results of an open uncontrolled chart review study of amantadine treatment for executive dysfunction syndrome in patients with dementia. All patients admitted to the neuropsychiatry or geriatric psychiatry inpatient units of Johns Hopkins Hospital in 2000 and 2001 who were treated empirically with amantadine for executive dysfunction syndrome were included in the review. Of the 30 patients whose cases were reviewed, 17 (57%) were at least "much improved," and most patients were discharged taking amantadine, suggesting that their physicians believed that they may have benefited from it. The medication was well tolerated in this frail group of patients. Most patients were taking one or more concurrent psychotropic medications, which may have contributed to the positive outcomes, Despite its limitations, this study offers preliminary data to support a controlled trial of amantadine in patients with executive dysfunction syndrome.

AB - This article reports the results of an open uncontrolled chart review study of amantadine treatment for executive dysfunction syndrome in patients with dementia. All patients admitted to the neuropsychiatry or geriatric psychiatry inpatient units of Johns Hopkins Hospital in 2000 and 2001 who were treated empirically with amantadine for executive dysfunction syndrome were included in the review. Of the 30 patients whose cases were reviewed, 17 (57%) were at least "much improved," and most patients were discharged taking amantadine, suggesting that their physicians believed that they may have benefited from it. The medication was well tolerated in this frail group of patients. Most patients were taking one or more concurrent psychotropic medications, which may have contributed to the positive outcomes, Despite its limitations, this study offers preliminary data to support a controlled trial of amantadine in patients with executive dysfunction syndrome.

UR - http://www.scopus.com/inward/record.url?scp=2442520119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442520119&partnerID=8YFLogxK

U2 - 10.1176/appi.psy.45.3.205

DO - 10.1176/appi.psy.45.3.205

M3 - Article

C2 - 15123844

AN - SCOPUS:2442520119

VL - 45

SP - 205

EP - 209

JO - Psychosomatics

JF - Psychosomatics

SN - 0033-3182

IS - 3

ER -